Furthermore, as seen in ETV6/RUNX1-rearranged and hyperdiploid ALL, some patients with favorable genetics but slow MRD clearance can be cured by intensifying their post-remission chemotherapy [11,17,27]. The gene discussed is ETV6; the disease is acute lymphoblastic leukemia.